comparemela.com

Gsk News News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK regulatory submission for myelofibrosis medicine momelotinib accepted for review by Japanese regulator

London: GSK plc has announced that the Ministry of Health, Labour and Welfare (MHLW), Japan, has accepted for review a new drug application (NDA) for momelotinib, a potential new medicine with a.

GSK regulatory submission accepted for review by Japanese regulator for Nucala use in adults with chronic rhinosinusitis with nasal polyps

London: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted for review a supplementary new drug application (sJNDA) for Nucala (mepolizumab), a.

Canada court dismissed Zantac litigation: GSK

Bengaluru: The British Columbia Supreme Court dismissed a proposed class action in Canada against heartburn drug Zantac over increased cancer risk, drugmaker GSK Plc said on Friday.First approved in.

GSK RSV vaccine for older adults under Japanese regulator review

GSK to close commercial operations in Kenya next year

The manufacturing facility in Kenya is operated by Haleon and GSK was importing medicines and vaccines, whose sales were being handled by its management office, which will shut down.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.